John C. Phillips, Jr.

Megan C. Haney

Robert F. Vroom

Jack B. Blumenfeld

Aaron Stiefel

Soumitra Deka

Jeffrey Martin

Daniel Dinapoli

Maryellen Noreika

Victoria L. Reines

Stephanie M. Piper

Philip A. Smithback

PF Prism CV

C P Pharmaceuticals Intl CV

Breckenridge Pharmaceutical Inc

Pfizer Inc

Last Docket Entry Date

Total Docket Entries

ANDA filing triggers Pfizer challenge to generic Xeljanz®, accused of infringing patents on the `crystalline form` and active compound for rheumatoid arthritis.

1:17-cv-00302 | Pfizer Inc v. Breckenridge Pharmaceutical Inc | Ex Parte

United States District of Delaware

Name	Ratings
Pfizer Inc	L5A
PF Prism CV	L5A
C P Pharmaceuticals Intl CV	L5A

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5A
Jack B. Blumenfeld	L5A
Maryellen Noreika	L4A
Arnold & Porter Kaye Scholer LLP	L4B
Aaron Stiefel	L5B
Daniel Dinapoli	L5B
Soumitra Deka	L5C
Jeffrey Martin	L3C
Philip A. Smithback	L3-- --
Victoria L. Reines	---- --
Stephanie M. Piper	---- --

Name	Ratings
Phillips Goldman McLaughlin & Hall PA	L1E
John C. Phillips, Jr.	---- --
Megan C. Haney	---- --
Breckenridge Pharmaceutical Inc	---- --
Robert F. Vroom	L4E